We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

All-in-One Test Provides Faster Testing for Persistent Diarrhea

By LabMedica International staff writers
Posted on 18 Apr 2017
Print article
Image: The IBcause kit comes with everything needed for private stool sample collection (Photo courtesy of Prometheus Laboratories).
Image: The IBcause kit comes with everything needed for private stool sample collection (Photo courtesy of Prometheus Laboratories).
A convenient new multiplex diagnostic assay evaluates a unique combination of 20 stool and blood serum measures all at once, assisting healthcare providers to more rapidly test for many common causes of persistent diarrhea, compared to sequential testing with standard workup for persistent diarrhea.

Current methods of identifying the underlying cause(s) of persistent diarrhea can be slow, time-consuming, and frustrating. To help more quickly and effectively diagnose the cause(s) of a patient’s ongoing diarrhea (which may be referred to as persistent or chronic), Prometheus Laboratories (San Diego, CA, USA), of Nestlé Health Science (Epalinges, Switzerland), has launch their new assay “IBcause.”

"IBcause may help healthcare providers get to a diagnosis faster and a specific treatment plan sooner than sequential testing and empiric treatment for persistent diarrhea," said Warren Cresswell, Prometheus Diagnostics (Dx), "IBcause brings many key stool and serum assays together, including a proprietary assay that is not available elsewhere in the United States to test for bile acid malabsorption (BAM). BAM may affect up to 50% of patients with unexplained persistent diarrhea and is often overlooked or misdiagnosed as diarrhea-predominant irritable bowel syndrome (IBS-D)."

As part of patient support, new resources have been developed, including a guide, videos, a website, and telephone support to address patient questions. A convenient online portal, PrometheusOnline.com, for obtaining fast test results and information for patients, as well as test ordering and results for healthcare providers, is also available.

Gold Supplier
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Gold Supplier
CLIA Analyzer
UHF RFID Tag and Inlay

Print article



view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more


view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The Coris acquisition provides Avacta with a broad, professional-use rapid test product portfolio (Photo courtesy of Coris Bioconcept)

Avacta Expands Diagnostics Portfolio with Acquisition of Rapid Test Maker Coris Bioconcept

Avacta Group plc (London, UK), a life sciences company developing oncology drugs and diagnostics, has acquired Coris Bioconcept SRL (Gembloux, Belgium) for an upfront cash consideration of GBP 7.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.